Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Affibody Molecules in Biotechnological and Medical Applications
KTH, Skolan för bioteknologi (BIO), Proteinteknologi.ORCID-id: 0000-0002-9282-0174
KTH, Skolan för bioteknologi (BIO), Proteinteknologi.ORCID-id: 0000-0002-5391-600X
KTH, Skolan för bioteknologi (BIO), Proteinteknologi.ORCID-id: 0000-0002-0695-5188
Vise andre og tillknytning
2017 (engelsk)Inngår i: Trends in Biotechnology, ISSN 0167-7799, E-ISSN 1879-3096, Vol. 35, nr 8, s. 691-712Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Affibody molecules are small (6.5-kDa) affinity proteins based on a three-helix bundle domain framework. Since their introduction 20 years ago as an alternative to antibodies for biotechnological applications, the first therapeutic affibody molecules have now entered clinical development and more than 400 studies have been published in which affibody molecules have been developed and used in a variety of contexts. In this review, we focus primarily on efforts over the past 5 years to explore the potential of affibody molecules for medical applications in oncology, neurodegenerative, and inflammation disorders, including molecular imaging, receptor signal blocking, and delivery of toxic payloads. In addition, we describe recent examples of biotechnological applications, in which affibody molecules have been exploited as modular affinity fusion partners.

sted, utgiver, år, opplag, sider
Elsevier, 2017. Vol. 35, nr 8, s. 691-712
HSV kategori
Identifikatorer
URN: urn:nbn:se:kth:diva-211597DOI: 10.1016/j.tibtech.2017.04.007ISI: 000405847200005OAI: oai:DiVA.org:kth-211597DiVA, id: diva2:1131680
Merknad

QC 20170815

Tilgjengelig fra: 2017-08-15 Laget: 2017-08-15 Sist oppdatert: 2017-08-15bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekst

Personposter BETA

Ståhl, StefanGräslund, TorbjörnEriksson Karlström, AmelieNygren, Per-ÅkeLöfblom, John

Søk i DiVA

Av forfatter/redaktør
Ståhl, StefanGräslund, TorbjörnEriksson Karlström, AmelieNygren, Per-ÅkeLöfblom, John
Av organisasjonen
I samme tidsskrift
Trends in Biotechnology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 270 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf